The EPA told the AHA’s Association for the Healthcare Environment that recent testing gives the agency reason to believe sBioMed’s Steriplex SD Part A and Steriplex SD Activator Part B products are “misbranded pesticides” and are not effective against C. diff, as advertised.
The order requires sBioMed to voluntarily recall the products from the market until the compliance issues can be resolved.
EPA officials also recommend hospitals and healthcare facilities that use these pesticides “find alternative EPA-registered products which control [C. diff].”
More articles on C. diff:
Abnormal vitals and blood tests linked to C. diff complications
C. diff is over diagnosed by popular molecular tests, study finds
Which 9 hospitals reported zero C. diff and MRSA infections?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
